MPEP § 2413.01 — Parts of the “Sequence Listing XML”

Ninth Edition, Revision 01.2024 · last revised R-01.2024

[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]

The constituent parts of the “Sequence Listing XML” are identified in multiple paragraphs of WIPO Standard ST.26 and have been specifically incorporated into the USPTO rules of practice at 37 CFR 1.839.

Contents

Cited authority